SHPH

Shuttle Pharmaceuticals Holdings, Inc. SHPH

SHPH
Shuttle Pharmaceuticals Holdings, Inc. AKAN
Akanda Corp. HSCS
HeartSciences Inc. UPC
Universe Pharmaceuticals Inc. TOVX
Theriva Biologics, Inc. BIVI
BioVie Inc. ISPC
iSpecimen Inc. RDHL
RedHill Biopharma Ltd. MSPR
MSP Recovery, Inc. BBLG
Bone Biologics Corporation

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SHPH AKAN HSCS UPC TOVX BIVI ISPC RDHL MSPR BBLG
6M -47.98 % -86.06 % -32.38 % 18.70 % -55.84 % -88.13 % -57.18 % -40.72 % -99.22 % -67.75 %
YTD -91.54 % -90.10 % -30.75 % -83.35 % -88.28 % -94.17 % -86.01 % -82.03 % -99.57 % -69.61 %
1Y -90.66 % -89.14 % -29.81 % -83.10 % -89.01 % -94.09 % -86.16 % -81.89 % -99.45 % -66.85 %
3Y -99.50 % -99.85 % -97.02 % -99.93 % -98.07 % -99.79 % -98.44 % -99.17 % -99.55 % -98.73 %
5Y -99.98 % -100.00 % -98.48 % -99.97 % -99.79 % -99.92 % -99.73 % -99.99 % -99.55 % -99.95 %
10Y -99.98 % -100.00 % -98.48 % -99.97 % -100.00 % -99.15 % -99.73 % -99.99 % -99.55 % -99.95 %
From the beginning -99.98 % -100.00 % -98.48 % -99.97 % -100.00 % -99.66 % -99.73 % -99.99 % -99.55 % -99.95 %

Dividend